Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR) | Zendy

Elisa Chiadini | Zendy; Matteo Canale | Zendy; Angelo Delmonte | Zendy; Claudio Dazzi | Zendy; Cláudia Casanova | Zendy; Laura Capelli | Zendy; Marita Mariotti | Zendy; Maximilian Papi | Zendy; Alessandro Gamboni | Zendy; Maurizio Puccetti | Zendy; Sara Bravaccini | Zendy; Alessandra Dubini | Zendy; Daniele Calistri | Zendy; Lucio Crinó | Zendy; Paola Ulivi | Zendy

Open Access

Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR)

Author(s) -

Elisa Chiadini,

Matteo Canale,

Angelo Delmonte,

Claudio Dazzi,

Cláudia Casanova,

Laura Capelli,

Marita Mariotti,

Maximilian Papi,

Alessandro Gamboni,

Maurizio Puccetti,

Sara Bravaccini,

Alessandra Dubini,

Daniele Calistri,

Lucio Crinó,

Paola Ulivi

Publication year - 2018

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2018.07.22

Subject(s) - epidermal growth factor receptor , medicine , lung cancer , lung , cancer research , epidermal growth factor , oncology , chromosomal translocation , receptor , cell , bioinformatics , pathology , biology , genetics , gene

Molecular diagnostics for non-small cell lung cancer (NSCLC) has become the standard of care for personalized treatment. Epidermal growth factor receptor ( EGFR ) mutation and EML4-ALK translocation represent the two most important alterations in first-line treatment decision-making. However, other potentially targetable alterations are also present.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research